Though further work will be necessary, we anticipate that the synthetic lethal interaction we uncovered between SETX and FA proteins may direct new strategies for cancer treatment, with similar therapeutic applications as the successful use of PARP inhibitors in BRCA-mutant tumors. This evidence concerns the gene FANCA and cancer.